- USPTO Issues Final Rejection of Magnolia Medical’s ‘483 Patent at Issue in Litigation
- Kurin, Inc. Reports Record Revenue for Q3 2023
- Kurin, Inc. Named 2023 Diverse Supplier of the Year by Vizient
- USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
- Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
- Kurin Launches Kurin Jet, Redefining the Blood Culture Contamination Device Market
- Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations
- Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
- ENA Welcomes Kurin to 2023 Corporate Engagement Council
- Kurin, Inc. Announces Successful FDA Audit
Need more information?
Click here to connect with Kurin.